Fundz

Harpoon Therapeutics, Inc. reported raising $70 Million in an initial SEC Form D filing, from an offering of $70 Million

RECENTLY ACQUIREDNov 26, 2018

Amount Raised

$70 Million

$70 Million sold, per SEC Form D (first sale Nov 26, 2018)

Round Type

Venture

South San FranciscoBiotechnologyPharmaceutical Manufacturing

Quick answer

Harpoon Therapeutics raised $70 Million in a funding round, dated November 26, 2018. Harpoon Therapeutics is based in South San Francisco, California, United States.

How much did Harpoon Therapeutics raise?
Harpoon Therapeutics raised $70 Million in a funding round on November 26, 2018.
What does Harpoon Therapeutics do?
Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.
Where is Harpoon Therapeutics based and how big is it?
Harpoon Therapeutics is based in South San Francisco, California, United States. Fundz records about 23 employees.
Who are the decision-makers at Harpoon Therapeutics?
Fundz holds 2 contacts at Harpoon Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical Manufacturing and Biotechnology around the same time

Companies in the same sectors as Harpoon Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Embleema raised $3M (Seed) on January 9, 2019.
  • Sirnaomics, Inc. raised $25M on January 8, 2019.
  • ALUNG TECHNOLOGIES INC raised $5M (Seed) on January 8, 2019.
  • Medical 21 raised an undisclosed amount on January 8, 2019.
  • USBC raised $29K on January 8, 2019.
  • Sirnaomics, Inc. raised $11M on January 8, 2019.

Who to call at Harpoon Therapeutics, and when

A new round usually means Harpoon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Harpoon Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Harpoon Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Harpoon Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Harpoon Therapeutics

Location

131 Oyster Point Boulevard, Suite 300

South San Francisco, California, United States

About

Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC®) platform, Harpoon is developing a pipeline of novel TriTACs initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon has also developed a proprietary ProTriTAC™ platform, which applies a prodrug concept to its TriTAC platform to create a therapeutic T cell engager that remains inactive until it reaches the tumor. Harpoon’s third proprietary technology platform, extended release TriTAC-XR, is designed to mitigate cytokine release syndrome. For more information, please visit www.harpoontx.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Harpoon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts8 people are listed at Harpoon Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Harpoon Therapeutics's next move

See what Strategic adds

Harpoon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.